IN8BIO, INC., 2025-12-30
An SEC Form D private-offering notice from New York, NY, a $40,239,043 filer-stated offering target in Biotech. Filed 2025-12-30. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing gamma-delta T cell therapies and T cell engagers for cancer, with Phase 1/2 programs in glioblastoma and leukemia.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Popcorn Labs, Inc., 2025-12-31, $16M, New York, NY
- Healionics CORP, 2025-12-31, $20M, Seattle, WA
- Macrocosm, Inc., 2025-12-31, $4M, Brooklyn, NY
- Cadrenal Therapeutics, Inc., 2025-12-31, $4.4M, Ponte Vedra, FL
- Coaster Media Inc., 2025-12-30, $150K, Brooklyn, NY
- Nacuity Pharmaceuticals, Inc., 2025-12-30, $30M, Fort Worth, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.